Cambridge Diabetes Risk Score
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–0.11
- Moderate Risk0.11–0.29
- High Risk0.29–1
The Cambridge Diabetes Risk Score calculates predicting risk of having previously undiagnosed type 2 diabetes based on clinical and demographic factors. Key inputs include gender. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts risk of having previously undiagnosed type 2 diabetes based on clinical and demographic factors. Developed for population screening and identification of high-risk individuals who should undergo diabetes testing.
Clinical Indication
The Cambridge Diabetes Risk Score is indicated for bedside clinical practice to support Predicts risk of having previously undiagnosed type 2 diabetes based on clinical and demographic factors. Developed for population screening and identification of high-risk individuals who should undergo diabetes testing.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
Probability = 1 / (1 + e^-(α + Σ(βn × xn))), where α = -6.322 and βn are coefficients for each risk factor
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| gender | string | Yes | Patient's biological sex |
| age | integer | Yes | Patient's age in years(years) |
| bmi_category | string | Yes | Body Mass Index category: <25 (normal), 25-27.5 (overweight), 27.5-30 (overweight), ≥30 (obese) |
| family_history | string | Yes | Family history of diabetes in first-degree relatives |
| smoking_status | string | Yes | Current smoking status |
| antihypertensive_use | string | Yes | Currently prescribed antihypertensive (blood pressure) medication |
| steroid_use | string | Yes | Currently prescribed steroid medication (oral corticosteroids) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0.11 | Low Risk | Low probability of undiagnosed diabetes |
| 0.11–0.29 | Moderate Risk | Moderate probability of undiagnosed diabetes |
| 0.29–1 | High Risk | High probability of undiagnosed diabetes |
Evidence-Based References (EBM)
- Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev. 2000 May-Jun;16(3):164-71. doi: 10.1002/1520-7560(200005/06)16:3<164::aid-dmrr103>3.0.co;2-r.DOI: 10.1002/1520-7560(200005/06)16:3
- Wareham NJ, Griffin SJ. Risk scores for predicting type 2 diabetes: comparing axes and spades. Diabetologia. 2011 May;54(5):994-5. doi: 10.1007/s00125-011-2101-0.DOI: 10.1007/s00125-011-2101-0
- Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ. A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. Fam Pract. 2008 Jun;25(3):191-6. doi: 10.1093/fampra/cmn024.DOI: 10.1093/fampra/cmn024